Perfect Minds Co., Ltd. Reports 33.34% Stake in Jyong Biotech Ltd. (MENS)

On April 24, 2026, Perfect Minds Co., Ltd., along with affiliated reporting persons, filed a Schedule 13D disclosing a 33.34% ownership stake in Jyong Biotech Ltd. (ticker: MENS). The filing reports the acquisition of 25,349,500 ordinary shares for an aggregate purchase price of approximately $5,760,075. The transaction event occurred on June 16, 2025. Perfect Minds Co., Ltd. is a holding company organized under the laws of Seychelles and is a wholly owned subsidiary of Innovation Global Group Limited, which is in turn owned by The Innovation Trust. Ms. Kuo Fu-Feng, the settlor of The Innovation Trust and the CEO/Chairwoman of Jyong Biotech Ltd., maintains sole voting and dispositive power over the shares. The reporting persons indicated that the shares were acquired for investment purposes. This filing marks a significant increase from a previously reported 0% position, establishing the reporting group as a major stakeholder in the issuer.